S&P Global Accelerates Private Markets Data Access with No-Code iLEVEL Snowflake Integration — Neutral
SPGI PRNewsWire — November 18, 2025New integration enhances decision-making by enabling faster analysis across multiple datasets, reducing time-to-insights NEW YORK , Nov. 18, 2025 /PRNewswire/ -- S&P Global (NYSE: SPGI) has announced the launch of its iLEVEL Snowflake integration, a no-code solution that is designed to enable private markets investors to seamlessly extract core raw datasets from S&P Global's iLEVEL portfolio monitoring platform directly to their Snowflake environment. This integration continues to strengthen S&P Global's position as a leading private markets intelligence provider and follows a series of strategic announcements in this space including a collaboration with Cambridge Associates and Mercer to provide comprehensive private …
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19 — Neutral
PRPH GlobeNewsWire — November 18, 2025UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be presenting third quarter 2025 financial results on a virtual conference call hosted by Renmark Financial on November 19, 2025, at 2:00 pm EST. A press release detailing these results will be issued prior to the virtual conference call.
Edible Garden's New Poultry Mix Display Hits Walmart Stores as Holiday Season Kicks Off — Neutral
EDBL GlobeNewsWire — November 18, 2025BELVIDERE, NJ, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that its popular Poultry Mix—a fresh combination of rosemary, thyme, and sage—will be available at select Walmart locations in time for the upcoming holiday season. Offered in a larger 3 oz.
Freshpet, Inc. to Participate in the Morgan Stanley Global Consumer & Retail Conference — Neutral
FRPT GlobeNewsWire — November 18, 2025BEDMINSTER, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today announced that members of the executive management team will participate in the Morgan Stanley Global Consumer & Retail Conference in New York, NY.
Innventure Strengthens Corporate Governance with Appointment of Bruce Brown as Lead Independent Director — Neutral
INV MAGN GlobeNewsWire — November 18, 2025ORLANDO, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (Nasdaq: INV), an industrial growth conglomerate that commercializes breakthrough technologies, today announced that its Board of Directors has appointed Bruce Brown to serve as the Company's first Lead Independent Director, effective immediately.
OSS Expands Best-In-Class High Performance Compute Portfolio with the Launch of PCIe Gen 6 Product Line at SC25 — Neutral
OSS GlobeNewsWire — November 18, 2025Company to showcase next-generation PCIe 6.0 CopprLink™ cable adapters and new 4UPro-Max expansion accelerator for ultra-low latency, high-wattage AI workloads at Booth 2111 Latest innovation from OSS focused on supporting the next generation of commercial datacenters and edge computing markets ESCONDIDO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leading provider of rugged, enterprise-class compute solutions for artificial intelligence (AI), machine learning (ML), and sensor processing at the edge, today announced a portfolio of next-generation PCI Express® (PCIe®) 6.0 CopprLink™ cable adapters and a new 4UPro-Max PCIe expansion accelerator.
Genius Group sends Demand Notices to Stockbrokers Charles Schwab, Fidelity, Vanguard and Robinhood to Reinstate the Buy Button for GNS Shares — Neutral
GNS GlobeNewsWire — November 18, 2025SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group”, “GNS” or the “Company”), a leading AI-powered, Bitcoin-first education group, announced that it sent Demand Notices to four brokerage firms, Charles Schwab & Co., Inc. (“Schwab”), Fidelity Global Brokerage Group, Inc. (“Fidelity”), The Vanguard Group, Inc. (“Vanguard”) and Robinhood Markets, Inc. (“Robinhood”), (collectively “The Parties”) on November 17, 2025 to reinstate buy button functionality for investors to buy the Company's shares online as easily as they can sell shares. About Genius Group Genius Group (NYSE: GNS) is a Bitcoin-first business delivering AI powered, education and …
ZenaTech Expands Drone as a Service into Colorado's Commercial and Agricultural Markets Closing the Company's 12th Acquisition, Rampart Surveys — Neutral
ZENA GlobeNewsWire — November 18, 2025VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology business solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, today announces the closing of its acquisition of Rampart Surveys Inc., a Woodland Park, Colo.-based land surveying firm with nearly three decades of experience.
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access — Neutral
EBS GlobeNewsWire — November 18, 2025GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN® (naloxone HCl) Nasal Spray as the first FDA-approved nasal naloxone spray for emergency treatment of opioid overdose.
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference — Neutral
INMB GlobeNewsWire — November 18, 2025Boca Raton, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces two presentations at the upcoming 18th Clinical Trials on Alzheimer's Disease conference (CTAD), in San Diego, CA on December 1-4, 2025.
SCHMID wins Innovation Award productronica 2025 for InfinityLine L+ — Neutral
SHMD GlobeNewsWire — November 18, 2025SCHMID Group is proud to announce that its InfinityLine L+ has been awarded the Innovation Award productronica 2025 in the category Cluster PCB & EMS.
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference — Neutral
MBX GlobeNewsWire — November 18, 2025CARMEL, Ind., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that Kent Hawryluk, President and Chief Executive Officer, and Sam Azoulay, M.D., Chief Medical Officer, will present and participate in the 37th Annual Piper Sandler Healthcare Conference being held on December 2-4.
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed — Neutral
NSRX GlobeNewsWire — November 18, 2025The Phase 2 study is designed to address regulatory approval considerations by comparing bioavailability and pharmacokinetics of NS002 against EpiPen
Disguise Celebrates Three Consecutive Years as the #1 Costume Manufacturer YTD in the U.S., with Minecraft securing their Top License Spot, According to Circana — Neutral
JAKK GlobeNewsWire — November 18, 2025POWAY, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Disguise, Inc., the global costume division of leading toy and consumer products company JAKKS Pacific, Inc. (NASDAQ: JAKK), today announced that it has been ranked the #1 costume manufacturer in the U.S. for year-to-date (YTD) 2025, according to Circana (Source: Circana, LLC, Retail Tracking Service, Costumes Supercategory, Dollars Adjusted, Jan–Sept 2025 and Jan 2023–Dec 2024). This marks the third consecutive year Disguise has held the top spot, after previously rising from #2 in 2022 (Source: Circana, LLC, Retail Tracking Service, Costumes Supercategory, Dollars Adjusted, Jan–Sept 2025 vs. Jan–Dec 2022).
Cheer Holding Forms Special Committee to Evaluate the Two Preliminary Non-Binding Proposals to Acquire All of Its Shares — Neutral
CHR GlobeNewsWire — November 18, 2025BEIJING, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding,” or the “Company”), a leading provider of advanced mobile internet infrastructure and platform services, today announced that its Board of Directors (the “Board”) has formed a special committee (the “Special Committee”) to, among other things, evaluate (i) the preliminary non-binding proposal letter, dated November 1, 2025, that it received from Zhongsheng Dingxin Investment Fund Management (Beijing) Co., Ltd., an existing shareholder of the Company, proposing to acquire all of the outstanding Class A ordinary shares of the Company, par value $0.001 per share (“Class A Shares”) …
Vizsla Royalties Congratulates Vizsla Silver on the Positive Feasibility Study for the Panuco Project — Neutral
VZLA Newsfile Corp — November 18, 2025Vancouver, British Columbia--(Newsfile Corp. - November 18, 2025) - Vizsla Royalties Corp. (TSXV: VROY) (OTCQB: VROYF) ("Vizsla Royalties" or the "Company") congratulates Vizsla Silver Corp.("Vizsla Silver") on the positive results of the Feasibility Study on their flagship Panuco project in Sinaloa, Mexico ("Panuco"). "We are thrilled with the strength of the feasibility study and what it means for Vizsla Royalties royalty on Panuco" stated Michael Pettingell, CEO of Vizsla Royalties.
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference — Neutral
ENTX GlobeNewsWire — November 18, 2025JERUSALEM, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies, today announced that the Company's Chief Executive Officer, Miranda Toledano, will be participating in a fireside chat at the 8th Annual Evercore ISI Healthcare Conference, details as below.
Enliven Therapeutics: Notable Early Signals, But Too Many Assumptions To Justify A Buy — Positive
ELVN Seeking Alpha — November 18, 2025Enliven Therapeutics remains overvalued relative to its early-stage pipeline progress and current financials. ELVN-001 shows promising safety and efficacy signals in heavily pretreated CML patients, with a pivotal phase 3 trial planned for 2026. ELVN is well-capitalized, with over four years of cash runway, but faces a competitive and relatively small CML market.
Toast: Clover's Stumbles Show Toast's Widening Moat — Neutral
TOST Seeking Alpha — November 18, 2025Toast, Inc. (TOST) is upgraded to Strong Buy as its competitive moat widens and growth prospects remain robust. Toast can benefit from the struggles at key competitor Clover, winning more SMB restaurant deals, and deepening strategic partnerships like the recent Uber integration. Management sees clear paths to doubling US market share, is expanding internationally, and entering new verticals, supporting sustained 20%+ revenue growth.
YieldMax MSTR Option Income Strategy ETF (MSTY) offers high income via covered calls on volatile MSTR, but has suffered alongside MSTR's decline. MSTY's recent price drop is tied to MSTR's weakness and market volatility, not just NAV erosion, with distributions still attractive for income seekers. MSTY is best used as a small, aggressive allocation within a diversified income portfolio, not as a core holding due to its risk profile.